Showing 15 posts of 94 posts found.


MSD buys Peloton Therapeutics in deal worth $2.1 billion

May 22, 2019
Research and Development Cancer, MSD, acquisition, biotech, deal, oncology, pharma

MSD has agreed to acquire all outstanding shares in Peloton Therapeutics in a deal worth up to $2.1 billion. US …

Biogen boosts ophthalmology portfolio with $800m acquisition of gene therapy firm Nightstar

March 4, 2019
Sales and Marketing Biogen, Nightstar, acquisition, pharma

Biogen has announced it has inked an agreement to acquire clinical-stage gene therapy firm Nightstar for a total value of …


Disapproval from top shareholder throws $74bn BMS/Celgene merger into doubt

February 28, 2019
Sales and Marketing Bristol-Myers Squibb, Celgene, acquisition, pharma

The news kicked off 2009 with a bang when Bristol-Myers Squibb announced it intended to acquire Celgene for $74 billion, …


Ipsen shells out $1.31bn to acquire rare disease specialist Clementia Pharmaceuticals

February 25, 2019
Sales and Marketing Clementia pharmaceuticals, acquisition, ipsen, rare disease

In a bid to boost its rare disease portfolio prospects, Ipsen has revealed its intention to acquire Clementia Pharmaceuticals, with …

Roche set to acquire Spark Therapeutics in $4.8 billion deal

February 25, 2019
Sales and Marketing Roche, Spark Therapeutics, acquisition, gene therapy, pharma

Roche is set to fully acquire gene therapy Spark Therapeutics after entering into a definitive merger agreement, after the Boards …


Takeda completes Shire acquisition

January 8, 2019
Manufacturing and Production M&A, MA, Shire, Takeda, acquisition, deal, pharma

Japanese firm Takeda Pharmaceuticals has successfully completed its acquisition of Shire Plc. The long anticipated deal has propelled the firm …


AbbVie records an estimated $4billion in impairment charges after failure of cancer drug Rova-T

January 8, 2019
Manufacturing and Production AbbVie, M&A, MA, Stemcentrx, acquisition, rova-t

US firm AbbVie has said that it will record an estimated $4 billion in impairment charges related to the abandonment …


BMS to acquire Celgene for $74 billion in biggest-ever pharma deal

January 4, 2019
Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, acquisition, pharma

Starting off 2019 with a bang, Bristol-Myers Squibb has announced its intention to acquire fellow drugmaker Celgene as part of …

Takeda shareholders approve $62bn Shire acquisition

December 6, 2018
Business Services Ireland, Japan, M&A, MA, Shire, Takeda, acquisition

Japanese firm Takeda have gained shareholders’ approval for the $62 billion acquisition of the Irish headquartered company Shire Plc. The …

GSK to acquire oncology biotech Tesaro for $5.1 billion

December 3, 2018
Sales and Marketing GSK, GlaxoSmtihKline, Tesaro, acquisition, oncology, pharma

GlaxoSmithKline is set to acquire US-based oncology biotech Tesaro after both companies signed a definitive agreement with an aggregate cash …


Novartis denies potential split with Sandoz

November 15, 2018
Business Services, Manufacturing and Production Business, M&A, MA, Novartis, Sandoz, acquisition, mergers

Swiss newspaper Tages-Anzeiger has reported that Novartis is preparing for a split with long-term partner Sandoz. The two companies merged …


Allergan acquires neurotoxin specialist Bonti in $195m deal

September 17, 2018
Sales and Marketing Allergan, Bonti, Botox, Neurotoxin, acquisition, deal

The Dublin-headquartered multinational Allergan have agreed to acquire the clinical stage biotech Bonti in a deal worth more than $195 …


Otsuka snaps up Visterra in $430 million deal

July 12, 2018
Research and Development, Sales and Marketing Otsuka, Visterra, acquisition, pharma

Otsuka Pharmaceutical has announced it has reached a definitive, board-approved agreement with Visterra to acquire the latter company in an …


Takeda to sell Osaka site to soften Shire deal’s financial impact

July 5, 2018
Manufacturing and Production, Sales and Marketing Japan, Osaka, Shire, Takeda, acquisition, pharma

It’s one of the biggest acquisitions the industry has seen at a total value of $63 billion and after weeks …


Lilly chalks up another acquisition with AurKa for $575m

May 14, 2018
Manufacturing and Production, Sales and Marketing AurKa, Cancer, Eli Lilly, acquisition, oncology, pharma

Swiftly following up its $1.6 billion splash to pick up Armo BioSciences last week, Eli Lilly has agreed to acquire …

Latest content